Cognex (CGNX) VP Laura MacDonald sells shares after option exercise

Rhea-AI Filing Summary

Cognex Corp VP and PAO Laura A. MacDonald reported option exercises and share sales on 02/12/2026. She exercised 12,500 non-qualified stock options at $38.39 per share, receiving an equal number of common shares.

MacDonald then made open-market sales totaling 14,881 common shares: 2,381 shares at $56.56 and 12,500 shares at $57.2707, pursuant to Rule 10b5-1 trading plans. After these transactions, she directly owned 2,212 common shares, plus various option and restricted stock unit awards, and 20 shares were held indirectly by her child with beneficial ownership disclaimed except for any pecuniary interest.

Insider Trade Summary

Net Seller: 14,881 shares ($850,553)

Net Sell 18 txns

Insider MACDONALD LAURA ANN

Role VP and PAO

Sold 14,881 shs ($851K)

Type	Security	Shares	Price	Value
Exercise	Non-Qualified Stock Option (right to buy)	12,500	$0.00	--
Sale	Common Stock	2,381	$56.56	$135K
Exercise	Common Stock	12,500	$38.39	$480K
Sale	Common Stock	12,500	$57.2707	$716K
holding	Non-Qualified Stock Option (right to buy)	--	--	--
holding	Non-Qualified Stock Option (right to buy)	--	--	--
holding	Non-Qualified Stock Option (right to buy)	--	--	--
holding	Non-Qualified Stock Option (right to buy)	--	--	--
holding	Non-Qualified Stock Option (right to buy)	--	--	--
holding	Non-Qualified Stock Option (right to buy)	--	--	--
holding	Non-Qualified Stock Option (right to buy)	--	--	--
holding	Non-Qualified Stock Option (right to buy)	--	--	--
holding	Non-Qualified Stock Option (right to buy)	--	--	--
holding	Restricted Stock Unit	--	--	--
holding	Restricted Stock Unit	--	--	--
holding	Restricted Stock Unit	--	--	--
holding	Restricted Stock Unit	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 0 shares (Direct); Common Stock — 2,212 shares (Direct); Restricted Stock Unit — 2,754 shares (Direct); Common Stock — 20 shares (Indirect, By Child)

Footnotes (1)

1. These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Held by reporting person's child. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MACDONALD LAURA ANN

(Last) (First) (Middle)

1 VISION DRIVE

(Street)

NATICK MA 01760

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COGNEX CORP [ CGNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP and PAO

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/12/2026		S(1)		2,381	D	$56.56	2,212	D
Common Stock	02/12/2026		M(2)		12,500	A	$38.39	14,712	D
Common Stock	02/12/2026		S(2)		12,500	D	$57.2707	2,212	D
Common Stock								20	I	By Child(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$38.39	02/12/2026		M(2)			12,500	02/21/2018	02/21/2027	Common Stock	12,500	$0.0	0	D
Non-Qualified Stock Option (right to buy)	$33.04							02/18/2026	02/18/2035	Common Stock	33,168		33,168	D
Non-Qualified Stock Option (right to buy)	$39.44							02/20/2025	02/20/2034	Common Stock	37,698		37,698	D
Non-Qualified Stock Option (right to buy)	$47.21							02/21/2024	02/21/2033	Common Stock	30,492		30,492	D
Non-Qualified Stock Option (right to buy)	$48.28							05/01/2022	05/01/2029	Common Stock	10,000		10,000	D
Non-Qualified Stock Option (right to buy)	$50.94							02/18/2021	02/18/2030	Common Stock	42,500		42,500	D
Non-Qualified Stock Option (right to buy)	$51.49							02/19/2020	02/19/2029	Common Stock	30,000		30,000	D
Non-Qualified Stock Option (right to buy)	$56.44							02/20/2019	02/20/2028	Common Stock	15,000		15,000	D
Non-Qualified Stock Option (right to buy)	$64.43							02/22/2023	02/22/2032	Common Stock	23,891		23,891	D
Non-Qualified Stock Option (right to buy)	$90.5							02/16/2022	02/16/2031	Common Stock	13,946		13,946	D
Restricted Stock Unit	$0.0							02/21/2024	02/21/2026	Common Stock	2,754		2,754	D
Restricted Stock Unit	$0.0							02/20/2025	02/20/2027	Common Stock	5,071		5,071	D
Restricted Stock Unit	$0.0							03/15/2025	03/15/2027	Common Stock	982		982	D
Restricted Stock Unit	$0.0							02/18/2026	02/18/2028	Common Stock	12,107		12,107	D

Explanation of Responses:

1. These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

2. These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

3. Held by reporting person's child. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.

	Laura A. MacDonald	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Cognex (CGNX) VP Laura MacDonald report?

Laura MacDonald reported exercising 12,500 non-qualified stock options and selling 14,881 Cognex common shares. The sales, executed in the open market under Rule 10b5-1 trading plans, were paired with option exercises at $38.39 per share, converting options into common stock before sale.

How many Cognex (CGNX) shares did Laura MacDonald sell and at what prices?

She sold 14,881 Cognex common shares in total: 2,381 shares at $56.56 per share and 12,500 shares at $57.2707 per share. Both transactions were coded as open-market sales, executed under pre-arranged Rule 10b5-1 trading plans disclosed in the filing footnotes.

What stock options did Laura MacDonald exercise at Cognex (CGNX)?

MacDonald exercised 12,500 non-qualified stock options with a $38.39 exercise price, originally granted on February 21, 2018 and expiring February 21, 2027. The exercise converted derivative rights into an equal number of Cognex common shares, which were then largely sold in open-market transactions.

How many Cognex (CGNX) shares does Laura MacDonald own after these transactions?

Following the reported trades, MacDonald directly owned 2,212 Cognex common shares. She also held multiple non-qualified stock option grants and restricted stock units, and 20 additional shares were held indirectly by her child, with beneficial ownership disclaimed except for any pecuniary interest described in the footnote.

Were Laura MacDonald’s Cognex (CGNX) trades under a Rule 10b5-1 plan?

Yes. The filing states that the open-market share sales and stock option exercises were conducted under trading plans adopted in accordance with Rule 10b5-1. Such plans allow insiders to pre-schedule trades, helping separate routine portfolio management from decisions based on later material nonpublic information.

What derivative and RSU holdings does Laura MacDonald retain at Cognex (CGNX)?

After the transactions, MacDonald retained several non-qualified stock option awards with varying exercise prices and expirations, including positions for 33,168, 37,698, 30,492, 10,000, 42,500, 30,000, 15,000, 23,891 and 13,946 shares. She also held restricted stock units covering 2,754, 5,071, 982 and 12,107 shares.